Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
Justine M. Kahn(Columbia University Irving Medical Center), Steven Z. Pavletic(National Institutes of Health), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Kristin Page(Medical College of Wisconsin), Seth J. Rotz(Cleveland Clinic), Robert J. Hayashi(Washington University in St. Louis), Andrew Daly, Mary E.D. Flowers(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Edward A. Copelan(Levine Cancer Institute), Gerhard Hildebrandt(University of Missouri Health System), Nosha Farhadfar(University of Florida Health), Hemant S. Murthy(University of Florida), Saurabh Chhabra(Medical College of Wisconsin), Naynesh Kamani(American Association of Blood Banks), Kirsten M. Williams(National Institutes of Health), Amer Beitinjaneh(University of Miami), Raquel M. Schears(Mayo Clinic in Arizona), Peiman Hematti(UW Health University Hospital), Michael Byrne(Vanderbilt University Medical Center), Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Stephanie Bo‐Subait(National Marrow Donor Program), Blanche P. Alter(National Institutes of Health), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Allistair Abraham(Children's National), David Buchbinder(Children's Hospital of Orange County), Amy K. Keating(Boston Children's Hospital), Peter J. Shaw(Children's Hospital at Westmead), Lynda M. Vrooman(Boston Children's Hospital), Baldeep Wirk(Boston University), Sherif M. Badawy(Northwestern University), Ruta Brazauskas(Medical College of Wisconsin), Celalettin Üstün(Rush University Medical Center), Andrew R. Rezvani(Stanford Blood Center), Samantha Mayo(University of Toronto), Biju George(Westmead Hospital), Richard F. Olsson(AstraZeneca (Netherlands)), Jeffery J. Auletta(Nationwide Children's Hospital), Heather R. Tecca(University of Minnesota), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Larisa Broglie(Morgan Stanley Children's Hospital), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Rachel Phelan(Children's Hospital of Wisconsin), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), Rammurti T. Kamble(Baylor College of Medicine), Minoo Battiwala(National Heart Lung and Blood Institute), Kasiani C. Myers(Immune Deficiency Foundation), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Siddhartha Ganguly(University of Kansas Medical Center)
Cited by 32
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k